ARTICLE | Company News
Signum Dermalogix, Dermata Therapeutics deal
April 27, 2015 7:00 AM UTC
Signum granted Dermata exclusive, worldwide rights to SIG990. An IND for the rosacea candidate has been cleared by the FDA. Dermata is responsible for clinical development of the topical anti-inflamm...